289 related articles for article (PubMed ID: 26068564)
1. Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015.
Folaranmi T; Rubin L; Martin SW; Patel M; MacNeil JR;
MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(22):608-12. PubMed ID: 26068564
[TBL] [Abstract][Full Text] [Related]
2. Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine - Advisory Committee on Immunization Practices, 2016.
Patton ME; Stephens D; Moore K; MacNeil JR
MMWR Morb Mortal Wkly Rep; 2017 May; 66(19):509-513. PubMed ID: 28520709
[TBL] [Abstract][Full Text] [Related]
3. Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015.
MacNeil JR; Rubin L; Folaranmi T; Ortega-Sanchez IR; Patel M; Martin SW
MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(41):1171-6. PubMed ID: 26492381
[TBL] [Abstract][Full Text] [Related]
4. Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
Collins JP; Crowe SJ; Ortega-Sanchez IR; Bahta L; Campos-Outcalt D; Loehr J; Morgan RL; Poehling KA; McNamara LA
MMWR Morb Mortal Wkly Rep; 2024 Apr; 73(15):345-350. PubMed ID: 38635488
[TBL] [Abstract][Full Text] [Related]
5. A review of the immunogenicity, safety and current recommendations for the meningococcal serogroup B vaccine, MenB-FHbp.
Burman C; Alderfer J; Snow VT
J Clin Pharm Ther; 2020 Apr; 45(2):270-281. PubMed ID: 31820483
[TBL] [Abstract][Full Text] [Related]
6. Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020.
Mbaeyi SA; Bozio CH; Duffy J; Rubin LG; Hariri S; Stephens DS; MacNeil JR
MMWR Recomm Rep; 2020 Sep; 69(9):1-41. PubMed ID: 33417592
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for Serogroup B Meningococcal Vaccine for Persons 10 Years and Older.
COMMITTEE ON INFECTIOUS DISEASES
Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27573083
[TBL] [Abstract][Full Text] [Related]
8. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Cohn AC; MacNeil JR; Clark TA; Ortega-Sanchez IR; Briere EZ; Meissner HC; Baker CJ; Messonnier NE;
MMWR Recomm Rep; 2013 Mar; 62(RR-2):1-28. PubMed ID: 23515099
[TBL] [Abstract][Full Text] [Related]
9. Parental awareness and utilization of meningococcal serogroup B vaccines in the United States.
Srivastava A; Dempsey A; Galitsky A; Fahimi M; Huang L
BMC Public Health; 2020 Jul; 20(1):1109. PubMed ID: 32664872
[TBL] [Abstract][Full Text] [Related]
10. Meningococcal-group B (MenB) vaccine series completion and adherence to dosing schedule in the United States: A retrospective analysis by vaccine and payer type.
Packnett E; Irwin DE; Novy P; Watson PS; Whelan J; Moore-Schiltz L; Lucci M; Hogea C
Vaccine; 2019 Sep; 37(39):5899-5908. PubMed ID: 31443990
[TBL] [Abstract][Full Text] [Related]
11. Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):273. PubMed ID: 20224545
[TBL] [Abstract][Full Text] [Related]
12. MenB-FHbp Meningococcal Group B Vaccine (Trumenba
Shirley M; Taha MK
Drugs; 2018 Feb; 78(2):257-268. PubMed ID: 29380290
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®).
Gandhi A; Balmer P; York LJ
Postgrad Med; 2016 Aug; 128(6):548-56. PubMed ID: 27467048
[TBL] [Abstract][Full Text] [Related]
14. Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults.
Presa J; Burman C; Tort MJ; Cane A; Bocchini JA
Hum Vaccin Immunother; 2023 Dec; 19(1):2212570. PubMed ID: 37257838
[TBL] [Abstract][Full Text] [Related]
15. Implementation Experience With Meningococcal Serogroup B Vaccines in the United States: Impact of a Nonroutine Recommendation.
Fergie J; Howard A; Huang L; Srivastava A
Pediatr Infect Dis J; 2021 Mar; 40(3):269-275. PubMed ID: 33565815
[TBL] [Abstract][Full Text] [Related]
16. A physician's guide to the 2-dose schedule of MenB-FHbp vaccine.
McDaniel A; Dempsey A; Srivastava A
Hum Vaccin Immunother; 2019; 15(11):2729-2737. PubMed ID: 30932730
[TBL] [Abstract][Full Text] [Related]
17. Clinical data supporting a 2-dose schedule of MenB-FHbp, a bivalent meningococcal serogroup B vaccine, in adolescents and young adults.
Beeslaar J; Absalon J; Balmer P; Srivastava A; Maansson R; York LJ; Perez JL
Vaccine; 2018 Jun; 36(28):4004-4013. PubMed ID: 29861182
[TBL] [Abstract][Full Text] [Related]
18. Anti-Factor H Antibody Reactivity in Young Adults Vaccinated with a Meningococcal Serogroup B Vaccine Containing Factor H Binding Protein.
Sharkey K; Beernink PT; Langley JM; Gantt S; Quach C; Dold C; Liu Q; Galvan M; Granoff DM
mSphere; 2019 Jul; 4(4):. PubMed ID: 31270173
[TBL] [Abstract][Full Text] [Related]
19. Randomized Trial of 2 Schedules of Meningococcal B Vaccine in Adolescents and Young Adults, Canada
Langley JM; Gantt S; Quach C; Bettinger JA; Halperin SA; Mutch J; McNeil SA; Ward BJ; MacKinnon-Cameron D; Ye L; Marty K; Scheifele D; Brown E; Alcantara J;
Emerg Infect Dis; 2020 Mar; 26(3):454-462. PubMed ID: 32091358
[TBL] [Abstract][Full Text] [Related]
20. Disparities in healthcare providers' interpretations and implementations of ACIP's meningococcal vaccine recommendations.
Huang L; Goren A; Lee LK; Li VW; Dempsey A; Srivastava A
Hum Vaccin Immunother; 2020 Apr; 16(4):933-944. PubMed ID: 31634035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
